arrow
返回
S

Stuart C. Gordon

Henry Ford Health System

79H指数
625论文数
4.1W被引数
收录论文 256
发表时间
Response to Commentary on “Impact of Disease-Specific Treatment and NSBBs on Risk of PVT in Cirrhotic Patients With HCV or PBC”对“疾病特异性治疗和NSBBs对伴有HCV或PBC的肝硬化患者PVT风险的影响”一文的评论回复
err2026-08-13
err0
PREAI
errHumberto C. Gonzalez; Stuart C. Gordon; Sheri Trudeau; Trueman Wu; Lora Rupp; Christina Melkonian; Mark A. Schmidt; Yihe Daida; Amandeep K. Sahota; Christopher L. Bowlus; Mei Lu
err分享
err收藏
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infectionglecaprevir/pibrentasvir治疗有既往丙型肝炎病毒感染史个体的急性丙型肝炎病毒感染
err2026-06-24
err0
errOAAI
errChristoph Boesecke; Kimberly Workowski; Stuart C. Gordon; Barbra Cave; John Marcinak; Michael G. Miller; Dimitri Semizarov; Anne Welhaven; Axel Baumgarten
err分享
err收藏
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies塞拉德尔帕(Seladelpar)在原发性胆汁性胆管炎合并代偿期肝硬化患者中的疗效与安全性:来自RESPONSE和ASSURE研究的数据
err2026-05-01
err0
PREAI
errGordon, Stuart C.; Villamil, Alejandra; Jacobson, Ira M.; Lawitz, Eric J.; Younes, Ziad; Silveira, Marina G.; Bowlus, Christopher L.; Drenth, Joost P. H.; Vierling, John M.; Morgera, Ulrike; Vasura, Adam; Dalekos, George; Galli, Andrea; Rabinovitz, Mordechai; Heo, Jeong; Nevens, Frederik; Levy, Cynthia; Zhou, Yan; Carroll, Susheela; Crittenden, Daria B.
err分享
err收藏
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America—A 5-Year Analysis北美地区原发性硬化性胆管炎指南依从性差距分析——一项为期5年的研究
err2026-04-10
err0
PREAI
errAdrielly Martins; Anish Reddy; Richard Dean; Stuart C. Gordon; Daniel Pratt; Michael Li; Lisa Forman; Craig Lammert; Kidist Yiman; Juan Gallegos-Orozco; Elizabeth J. Carey; Alan Bonder; Barry L. Schlansky; Aldo J. Montano-Loza; Ellina Lytvyak; David S. Goldberg; Scott Naugler; Lei Yu; David Assis; Christopher L. Bowlus; Cynthia Levy
err分享
err收藏
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated AnalysisGlecaprevir/Pibrentasvir在慢性HCV感染合并症或多种合并用药参与者中的疗效与安全性:一项综合分析
err2026-04-08
err0
errOAAI
errCurtis Cooper; Shweta A. Raina; Lisa Johnson; Jordan J. Feld; Ashley Brown; Anthony Martinez; Brian Conway; Stuart C. Gordon; Tarik Asselah; Liz Uribe; Moming Li; Alexandru Iacob; John Marcinak; Dimitri Semizarov; Stanislas Pol
err分享
err收藏
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey妊娠期丙型肝炎治疗:医师观点——一项跨国多专科调查
err2026-04-06
err0
PREAI
errTatyana Kushner; Maria Buti; Mohamed El-Kassas; Yusuf Yilmaz; Hirokazu Takahashi; Yuichiro Eguchi; Stuart K. Roberts; Wah-Kheong Chan; Ming-Lung Yu; Ponsiano Ocama; Saira Khaderi; Manida Wungjiranirun; Ira M. Jacobson; Stuart C. Gordon; Aina Nicolas; John Ward; Neil Gupta; Lindsey Hiebert-Suwondo; Sheila Reynoso; Linda Henry; Maria Stepanova; George Papatheodoridis; Zobair M. Younossi; the Global Liver Council
err分享
err收藏
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC疾病特异性治疗和非选择性β受体阻滞剂对HCV或PBC肝硬化患者PVT风险的影响
err2026-04-03
err0
errOAAI
errHumberto C. Gonzalez; Stuart C. Gordon; Sheri Trudeau; Trueman Wu; Lora Rupp; Christina Melkonian; Mark A. Schmidt; Yihe G. Daida; Amandeep K. Sahota; Christopher L. Bowlus; Mei Lu
err分享
err收藏
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialCilofexor在非肝硬化原发性硬化性胆管炎(PRIMIS)中的应用:一项随机、双盲、多中心、安慰剂对照的III期临床试验
err2025-10-28
err0
PREAI
errMichael Trauner; Cynthia Levy; Atsushi Tanaka; Zachary Goodman; Douglas Thorburn; Deepak Joshi; Kimmo Salminen; Kidist Yimam; Hiroyuki Isayama; Aldo J Montano-Loza; Stephen Caldwell; Mark Danta; Martti Farkkila; Juan F Gallegos-Orozco; Stuart C Gordon; Holger Hinrichsen; Pietro Invernizzi; Raj Vuppalanchi; Kaiyi Zhu; Jun Xu; Xiangyu Liu; Xiaomin Lu; Gerald Crans; Shahla Bolbolan; Lisa Boyette; Muhsen Alani; William T Barchuk; Timothy R Watkins; Mark C Genovese; Christopher L Bowlus
err分享
err收藏
A multinational survey of physician knowledge about management of chronic hepatitis C关于慢性丙型肝炎管理知识的医师跨国调查
err2025-10-02
err0
errOAAI
errMohamed El-Kassas; Yusuf Yilmaz; Chun-Jen Liu; Marlen I. Castellanos Fernández; Yuichiro Eguchi; Khalid Al-Naamani; Doaa Abdeltawab; Mohammed A. Medhat; Wah-Kheong Chan; Stuart Gordon; Vasily Isakov; Ming Lung Yu; Maria Buti; George V. Papatheodoridis; Fatema Nader; Andrei Racila; Linda Henry; Maria Stepanova; Zobair M. Younossi
err分享
err收藏
Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Pooled Interim Results for up to 3 Years From the ASSURE Study
err2025-02-01
err0
PREAI
errLawitz, E. J.; Trivedi, P. J.; Kowdley, K. V.; Gordon, S. C.; Bowlus, C. L.; Londono, M. C.; Hirschfield, G. M.; Gulamhusein, A.; Crittenden, D. B.; Frigerio, F.; Zhuo, S.; Heusner, C.; Levy, C.
err分享
err收藏
Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis and Compensated Liver Cirrhosis in the Open-Label, Long-Term ASSURE Safety Study: Interim Results
err2024-10-01
err0
PREAI
errGordon, Stuart C.; Jacobson, Ira; Younes, Ziad H.; Silveira, Marina; Drenth, Joost; Morgera, Ulrike; Dalekos, George; Heo, Jeong; Yang, Ke; Heusner, Carrie; Crittenden, Daria B.; Mcwherter, Charles A.
err分享
err收藏
Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Interim Results for 2 Years From the ASSURE Study开放标签下塞拉德帕治疗原发性胆汁性胆管炎的长期有效性与安全性:ASSURE研究2年期的中期结果
err2024-10-01
err0
PREAI
errTrivedi, PJ; Levy, C; Kowdley, KV; Gordon, SC; Bowlus, CL; Hurtado, MCL; Hirschfield, GM; Gulamhusien, AF; Lawitz, EJ; Villamil, A; Cetina, AD; Mayo, MJ; Younes, ZH; Shibolet, O; Yimam, KK; Pratt, DS; Heo, J; Morgera, U; Andreone, P; Kremer, AE; Corpechot, C; Goel, A; Peyton, A; Elbeshbeshy, H; Crittenden, DB; Heusner, C; Proehl, S; Zhou, SQ; Mcwherter, CA
err分享
err收藏
err分享
err收藏
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
err2024-07-01
err2
errOAAI
errYounossi, Zobair M.; AlQahtani, Saleh A.; Funuyet-Salas, Jesus; Romero-Gomez, Manuel; Yilmaz, Yusuf; Keklikkiran, Caglayan; Alswat, Khalid; Yu, Ming-Lung; Liu, Chun-Jen; Fan, Jian-Gao; Zheng, Ming-Hua; Burra, Patrizia; Francque, Sven M.; Castera, Laurent; Schattenberg, Joern M.; Newsome, Philip N.; Allen, Alina M.; El-Kassas, Mohamed; Treeprasertsuk, Sombat; Hameed, Saeed; Wong, Vincent Wai-Sun; Zelber-Sagi, Shira; Takahashi, Hirokazu; Kawaguchi, Takumi; Fernandez, Marlen I. Castellanos; Duseja, Ajay; Arrese, Marco; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart C.; Fuchs, Michael; Eskridge, Wayne; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Gerber, Lynn; Lam, Brian; Fornaresio, Lisa; Nader, Fatema; Spearman, C. Wendy; Roberts, Stuart K.; Chan, Wah-Kheong; Silva, Marcelo; Racila, Andrei; Golabi, Pegah; Ananchuensook, Prooksa; Henry, Linda; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey, V
err分享
err收藏
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis (vol 41, pg 744, 2024)
err2024-04-10
err0
errOAAI
errLu, Mei; Rupp, Loralee B.; Melkonian, Christina; Trudeau, Sheri; Daida, Yihe G.; Schmidt, Mark A.; Gordon, Stuart C.
err分享
err收藏
Impact of antiviral treatment status on risk of extrahepatic cancers in patients with chronic hepatitis C
err2024-03-22
err0
PREAI
errTao, Menghua; Li, Jia; Wu, Trueman; Gordon, Stuart C.; Rupp, Loralee B.; Trudeau, Sheri; Holmberg, Scott D.; Moorman, Anne C.; Spradling, Philip R.; Teshale, Eyasu H.; Schmidt, Mark A.; Daida, Yihe G.; Lu, Mei
err分享
err收藏